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EMPLOYMENT OPPORTUNITIES
Postdoctoral Positions.—Two postdoctoral positions,
funded by a new grant from the National Institute of
Mental Health, are available for highly motivated in-
dividuals with excellent records of research to carry out
translational studies of polygenic neurological disease
through gene discovery, in Caenorhibditis elegans, of
pathophysiological mechanisms of serotonergic func-
tion. Candidates should have extensive experience in ge-
netics and molecular biology. A background in model
organisms, human genetics, or genomics is advanta-
geous. The projects will use genetic, molecular, genomic,
pharmacological, and biophysical approaches to gene
discovery through mutagenesis and RNAi screens of C.
elegans, followed by candidate gene association studies
in humans, allowing fellows growth opportunities across
disciplines, to identify and characterize components in
the signaling pathway of regulated serotonin production,
and to identify drugs that modify the response. The Uni-
versity of California, Irvine, is an equal opportunity em-
ployer committed to excellence through diversity. Please
send or e-mail a curriculum vitae, a description of re-
search interests and experience, and contact informa-
tion for three references to Dr. J. Jay Gargus (jjgargus
@uci.edu) or Dr. Ji. Y. Sze (jsze@uci.edu), School ofMed-
icine, UC Irvine, 340 Sprague Hall, Irvine, CA 92697.
Faculty Positions in Human Behavioral Genetics or De-
velopmental Neurogenetics.—The Vanderbilt Kennedy
Center for Research on Human Development and the
Department of Molecular Physiology and Biophysics in-
vites applications for tenure-track faculty positions at
any rank in human developmental neurogenetics or be-
havioral genetics. Potential areas of interest include in-
vestigation of the genetic and epigenetic bases of cog-
nitive and mental health disorders with a developmental
etiology. Research programs in humans and animal
models to investigate the role of gene-environment in-
teractions in the pathogenesis of neurodevelopmental
disorders are also of interest. The VKC has 1140 in-
vestigators in research programs that include develop-
mental neurobiology and plasticity, mood and emotion,
communication and learning, and families. Candidates
must have a Ph.D. and/or M.D. degree, at least 2 years
of postdoctoral experience, a strong publication record,
and evidence of the potential for obtaining extramural
funding for their research programs. Successful candi-
dates will receive a generous start-up package and will
be housed in newly constructed facilities. The institution
has outstanding core facilities, graduate and postdoc-
toral programs, and an interdisciplinary and collabo-
rative environment. Complete applications should in-
clude a curriculum vitae, reprints of key recent pub-
lications, a brief statement of current and future
research goals, and three letters of recommendation so-
licited by the applicant. Please send materials to Pat Lev-
itt, Ph.D., Director, Vanderbilt Kennedy Center for Re-
search on Human Development, Vanderbilt University,
Box 40 Peabody, 230 Appleton Place, Nashville, TN
37203. Vanderbilt University Medical Center is strongly
committed to diversity in attracting faculty to ﬁll these
positions and is an afﬁrmative action, equal opportunity
employer.
Postdoctoral Position in Human Sequence Variation and
Genetic Association Studies.—We seek a highly moti-
vated individual to join Deborah Nickerson’s laboratory
in the Department of Genome Sciences at the University
of Washington. Current research focuses on projects re-
lated to human sequence variation (SNPs) and analysis
of variation data generated from comprehensive DNA
resequencing of individuals from multiple populations;
see the SeattleSNPs Web site (http://pga.gs.washington
.edu/) and the Environmental Genome Project Web site
(http://egp.gs.washington.edu/). Speciﬁc work will focus
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on human population differences, haplotype analysis,
and linkage disequilibrium. This postdoctoral fellowwill
integrate human population genetics, genomics, and sta-
tistical analysis and the application of those concepts to
new and ongoing human genetic association studies. The
Nickerson Laboratory is a collaborative research group
focused on human sequence variation, evolution, and
genotype-phenotype correlations. The Nickerson labo-
ratory is a member of the Department of Genome Sci-
ences at the University of Washington located in Seattle,
WA. The department will be moving to a new, state-of-
the-art building in early 2006. See the Department of
Genome Sciences Web site (http://www.gs.washington
.edu/) for more information about the department and
the University of Washington. This position requires an
independent and highly motivated individual with dem-
onstrated expertise in human genetics, genomics, and
statistical analysis. Candidates with a background in ep-
idemiology and molecular biology are also strongly en-
couraged to apply. The successful applicant will have the
ability to manipulate large data sets (preferably using
PERL or some other high-level programming language),
a working knowledge of UNIX/LINUX operating sys-
tems, and genomic databases (e.g., NCBI). Educational
requirements include a Ph.D. in molecular biology, ge-
netics, epidemiology, bioinformatics, or a related ﬁeld.
Applicants should also have experience in human pop-
ulation genetics, phylogenetic methods, and genotyping
technologies. Experience in molecular biology and
high-throughput environments are pluses. Submit a let-
ter describing your professional interests and skills, a
curriculum vitae, relevant reprints, and the contact in-
formation for three references to Deborah A. Nicker-
son, University of Washington, Department of Genome
Science, Box 357730, Seattle, WA 98195. The Uni-
versity of Washington is an equal opportunity/afﬁrma-
tive action employer.
Fellowship Positions in Clinical BiochemicalGenetics.—
Mayo Clinic, in Rochester, MN, sponsors laboratory
genetics fellowships in clinical biochemical genetics, clin-
ical cytogenetics, and clinical molecular genetics. These
programs train individuals to direct clinical laboratories
in the area of specialization, after certiﬁcation by the
American Board of Medical Genetics (ABMG). Each fel-
lowship is part of an ABMG-accredited training pro-
gram. Currently, we are accepting applications for two
positions, starting July 1, 2006, for clinical biochemical
genetics. Applicants must have an M.D. and/or a Ph.D.
degree. Experience in human or medical genetics is pre-
ferred. Applications should include a letter of interest,
a curriculum vitae, and three letters of recommenda-
tion. Application information, including how to apply,
can be found at the Mayo School of Graduate Medi-
cal Education Web site (http://www.mayo.edu/msgme/
clinbio-gen-rch.html). Mayo Clinic’s Biochemical Ge-
netics Laboratory is an interdisciplinary group of la-
boratorians, geneticists, and pediatricians working in a
state-of-the-art environment. The mission of our labo-
ratory is to provide biochemical testing and result in-
terpretation of the highest quality for the diagnosis,
study, and clinical care of patients with inborn errors of
metabolism. These goals are accomplished by perform-
ing qualitative and quantitative determination of a large
and constantly growing number of diagnostic markers
and enzyme assays, by application of manual, auto-
mated, chromatographic, and mass spectrometry–based
methods. Applications and further inquiries should be
addressed to Dietrich Matern, M.D., FACMG, Mayo
Clinic College of Medicine, 200 First Street SW, Ro-
chester, MN 55905; fax: (507) 266-2888; e-mail:
Matern@mayo.edu. More information can be found on
Mayo Clinic’s laboratory genetics Web page (http://
www.mayoclinic.org/laboratorygenetics-rst/).
Faculty Appointment, Provincial Medical Genetics Pro-
gram.—The Children’s & Women’s Health Centre of
British Columbia and the University of British Columbia
(UBC) Department of Medical Genetics invite applica-
tions for a faculty appointment in the ProvincialMedical
Genetics Program. This program provides comprehen-
sive genetics services to the province of British Columbia
and has a long tradition of excellence in clinical care,
education, and research. The scope of clinical practice
includes prenatal genetic assessment and counseling,
dysmorphology, pediatric genetic assessment, and adult
clinical genetics. The program has a particular interest
in recruiting an individual who has an interest in pre-
natal genetic services, although individuals with a
broader interest in clinical genetics will also be consid-
ered. The Program includes a fully accredited Royal Col-
lege Residency Training Program in Medical Genetics
and Canadian College of Medical Genetics fellowships
in cytogenetics and clinical, biochemical, and molecular
genetics. The speciﬁc academic appointment will be
commensurate with the individual’s credentials. Can-
didates for this position must have anM.D. or equivalent
degree and must be eligible for licensing in the province
of British Columbia, as well as having specialist certi-
ﬁcation in medical genetics with either the Canadian
College of Medical Geneticists or the Royal College of
Physicians and Surgeons of Canada. Candidates will also
be considered if they possess comparable training and
certiﬁcation from other countries. The successful can-
didate will participate primarily in patient care, will be
expected to be involved in independent research pro-
grams, and will participate in teaching at the under-
graduate, graduate, and postgraduate levels. The salary
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for this position will be determined by qualiﬁcations and
clinical experience according to the Provincial Medical
Services Plan. Full beneﬁts, including sabbatical leave,
will be provided through this program. UBC and its
afﬁliates hire on the basis of merit and are committed
to employment equity. We encourage all qualiﬁed per-
sons to apply; however, Canadians and permanent res-
idents of Canada will be given priority. Applications will
be processed as they are received, with a deadline of
March 1, 2006. A start date as early as April 2006 is
anticipated. Applications including a curriculum vitae,
selected reprints, a statement of research/clinical inter-
ests, and the names of three references should be sent
to Dr. L.A. Clarke, Medical Director, ProvincialMedical
Genetics Program, UBC Department of Medical Genet-
ics, Children’s & Women’s Health Centre of British Co-
lumbia, 4500 Oak Street, Room C234, Vancouver, B.C.,
Canada V6H 3N1; telephone: (604) 875-2157; fax:
(604) 875-2376; e-mail: lclarke@cw.bc.ca
CONFERENCES
Great Lakes Chromosome Conference.—The 44th an-
nual Great Lakes Chromosome Conference (GLCC) will
be held May 18–19, 2006, in Toronto, Ontario, Canada.
This conference brings together clinical cytogeneticists,
cytogenetics fellows, and technologists in an informal
setting to examine the themes of cancer cytogenetics,
clinical problems, research programs, and new tech-
nologies. For additional information, please visit the
conference Web site (http://glccontario.tripod.com/
theGLCC/). If you wish to be added to the conference
e-mail list, please contact the meeting organizer, Marsha
Speevak (mspeevak@cvh.on.ca).
“Obstacles to Translation” Conference.—A conference
on “Obstacles to Translation—Overcoming the Barriers
between Gene Defect andMolecularly Targeted Therapy
of Heritable Skin Disorders” will be held March 1–2,
2006, at the University of California, San Francisco. This
conference will address the obstacles that have prevented
the translation of the knowledge of the gene defects un-
derlying dozens of heritable skin diseases into useful,
effective molecularly targeted therapies. The focus will
be on obstacles to identiﬁcation and production of useful
molecules, obstacles to their delivery and immunologic
barriers to their use, regulatory obstacles, and ﬁnancial
obstacles. Speakers will be from the academic, FDA,
pharmaceutical, biotechnology, and venture capital
communities. The organizers are Ervin Epstein, Barbara
Gilchrest, and Leonard Milstone. For more informa-
tion, see the conference Web site (http://dermatology
.medschool.ucsf.edu/obstacles.aspx) or e-mail epsteine
@derm.ucsf.edu
PATIENT REGISTRY FORMING
Turner Syndrome Aortic Dissection Registry.—Geneti-
cists, other professionals, parents, and individuals with
Turner syndrome are invited to join members of the
Turner Syndrome Society of the United States to estab-
lish the Turner Syndrome Aortic Dissection Registry.
Aortic dissection is more common in men in the general
population but does affect women with Turner Syn-
drome. In our review of 170 cases reported in theworld’s
literature, half occurred in women under 30 years of
age. Bicuspid aortic valve, aortic coarctation, and high
blood pressure are known risk factors for aortic dissec-
tion but may not always be present. In most reports,
details are lacking. The purpose of the Turner Syndrome
Aortic Dissection Registry is (1) to identify women with
Turner syndrome and aortic dissection, (2) to determine
risk factors for aortic dissection, and (3) to use this in-
formation to establish screening guidelines. Enrollment
can be done by an individual with Turner syndromewho
is currently under care for aortic dissection, by one of
her physicians, or by a physician or family member
who knew a deceased individual with Turner syndrome.
To enroll, either (1) use the online dissection registry re-
port form http://www.turner-syndrome-us.org/resource
/resources_detail.cfm?idp193); (2) contact the principal
investigator, Dr. Michael Silberbach, by telephone (503-
494-9899) or e-mail (silberbm@ohsu.edu); (3) contact
the Dissection Registry directly at mail code CDRC-P,
3181 SW Sam Jackson Park Road, Oregon Health &
Science University, Portland OR, 97201; or (4) call 1-
800-882-9996 and then press “3.”
